Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia

被引：0
|
作者：
Hiroyuki Hashimoto
Masato Takeuchi
Koji Kawakami
机构：
[1] Kyoto University,Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Allopurinol; Cardiovascular risk; Epidemiology; Febuxostat; Gout; Hyperuricemia; Xanthine oxidase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3075 / 3082
页数：7
相关论文
共 50 条
  • [1] Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia
    Hashimoto, Hiroyuki
    Takeuchi, Masato
    Kawakami, Koji
    CLINICAL RHEUMATOLOGY, 2023, 42 (11) : 3075 - 3082
  • [2] Correction to: Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia
    Hiroyuki Hashimoto
    Masato Takeuchi
    Koji Kawakami
    Clinical Rheumatology, 2024, 43 : 1271 - 1274
  • [3] Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia (vol 42, pg 3075, 2023)
    Hashimoto, Hiroyuki
    Takeuchi, Masato
    Kawakami, Koji
    CLINICAL RHEUMATOLOGY, 2024, 43 (3) : 1271 - 1274
  • [4] Association between urate-lowering therapy initiation and all-cause mortality in patients with type 2 diabetes and asymptomatic hyperuricemia
    Chen, Ruixuan
    Nie, Sheng
    Zhou, Shiyu
    Su, Licong
    Li, Yanqin
    Zhang, Xiaodong
    Luo, Fan
    Xu, Ruqi
    Gao, Qi
    Lin, Yuxin
    Guo, Zhixin
    Cao, Lisha
    Xu, Xin
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (06)
  • [5] Impact of Hyperuricemia and Urate-Lowering Agents on Cardiovascular Diseases
    Sosa, Franklin
    Shaban, Mohammed
    Lopez, Jose
    Duarte, Gustavo J.
    Jain, Swati
    Khizar, Asma
    Vittorio, Timothy
    Mishra, Rishabh
    Guerra, Miguel Rodriguez
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2024, 18
  • [6] ADHERENCE TO URATE-LOWERING THERAPY AFFECTS THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH GOUT
    Kim, M. J.
    Sun, J.
    Moon, K. W.
    Jang, Y.
    Shin, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 23 - 24
  • [7] Physiology of Hyperuricemia and Urate-Lowering Treatments
    Benn, Caroline L.
    Dua, Pinky
    Gurrell, Rachel
    Loudon, Peter
    Pike, Andrew
    Storer, R. Ian
    Vangjeli, Ciara
    FRONTIERS IN MEDICINE, 2018, 5
  • [8] Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
    Stamp, Lisa
    Dalbeth, Nicola
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (04) : 457 - 464
  • [9] Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in Japan
    Hakodaa, Masayuki
    Kasagi, Fumiyoshi
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 880 - 884
  • [10] Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis
    Zhang, Lin
    An, Kang
    Mou, Xingyu
    Zhang, Mei
    Su, Qiaoli
    Li, Shuangqing
    FRONTIERS IN PHARMACOLOGY, 2022, 12
12345